The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Desloratadine Glenmark 5 mg Tablets



Glenmark Arzneimittel GmbHPA22645/004/001

Main Information

Trade NameDesloratadine Glenmark 5 mg Tablets
Active SubstancesDesloratidine
Dosage FormTablet
Licence HolderGlenmark Arzneimittel GmbH
Licence NumberPA22645/004/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX27 desloratadine

Status

License statusAuthorised
Licence Issued20/04/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back